Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Pharmaceutical companies donating medicines in crisis situations

In the article, Catherine Gray and Suvi Karuranga, Researchers at the Access to Medicine Foundation, discuss the role of pharmaceutical companies in coordinated humanitarian responses to crisis situations.

Date

29 February 2016

Direct links

Read the full article

The current crisis in Syria is an extreme example of an acute need for coordinated humanitarian response. Eighteen million Syrians — 13.5 million people in Syria and 4.5 million asylum seekers and refugees outside the country — are in need of assistance, including access to medicines and vaccines.

The situation in Syria has prompted humanitarian stakeholders to re-examine the roles and potential responsibilities that different players should take in responding to major humanitarian crises. This includes the pharmaceutical industry — a significant private sector global health stakeholder.

This conversation will continue at upcoming international events such as the World Humanitarian Summit in May 2016. Indeed, WHS 2016 will focus specifically on the role of the private sector. 

The article was published on Devex. 

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved